Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Trends in the global immuno-oncology landscape.

Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM.

Nat Rev Drug Discov. 2018 Dec;17(12):922. doi: 10.1038/nrd.2018.202. Epub 2018 Oct 26.

PMID:
30361553
2.

Trends in the global immuno-oncology landscape.

Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM.

Nat Rev Drug Discov. 2018 Nov;17(11):783-784. doi: 10.1038/nrd.2018.167. Epub 2018 Oct 19. No abstract available. Erratum in: Nat Rev Drug Discov. 2018 Oct 26;:.

PMID:
30337722
3.

The global landscape of cancer cell therapy.

Tang J, Hubbard-Lucey VM, Pearce L, O'Donnell-Tormey J, Shalabi A.

Nat Rev Drug Discov. 2018 Jul;17(7):465-466. doi: 10.1038/nrd.2018.74. Epub 2018 May 25. No abstract available.

PMID:
29795477
4.

A Blueprint to Advance Colorectal Cancer Immunotherapies.

Le DT, Hubbard-Lucey VM, Morse MA, Heery CR, Dwyer A, Marsilje TH, Brodsky AN, Chan E, Deming DA, Diaz LA Jr, Fridman WH, Goldberg RM, Hamilton SR, Housseau F, Jaffee EM, Kang SP, Krishnamurthi SS, Lieu CH, Messersmith W, Sears CL, Segal NH, Yang A, Moss RA, Cha E, O'Donnell-Tormey J, Roach N, Davis AQ, McAbee K, Worrall S, Benson AB.

Cancer Immunol Res. 2017 Nov;5(11):942-949. doi: 10.1158/2326-6066.CIR-17-0375. Epub 2017 Oct 16.

5.

Cancer classification using the Immunoscore: a worldwide task force.

Galon J, Pagès F, Marincola FM, Angell HK, Thurin M, Lugli A, Zlobec I, Berger A, Bifulco C, Botti G, Tatangelo F, Britten CM, Kreiter S, Chouchane L, Delrio P, Arndt H, Asslaber M, Maio M, Masucci GV, Mihm M, Vidal-Vanaclocha F, Allison JP, Gnjatic S, Hakansson L, Huber C, Singh-Jasuja H, Ottensmeier C, Zwierzina H, Laghi L, Grizzi F, Ohashi PS, Shaw PA, Clarke BA, Wouters BG, Kawakami Y, Hazama S, Okuno K, Wang E, O'Donnell-Tormey J, Lagorce C, Pawelec G, Nishimura MI, Hawkins R, Lapointe R, Lundqvist A, Khleif SN, Ogino S, Gibbs P, Waring P, Sato N, Torigoe T, Itoh K, Patel PS, Shukla SN, Palmqvist R, Nagtegaal ID, Wang Y, D'Arrigo C, Kopetz S, Sinicrope FA, Trinchieri G, Gajewski TF, Ascierto PA, Fox BA.

J Transl Med. 2012 Oct 3;10:205. doi: 10.1186/1479-5876-10-205. Review.

6.

The Cancer Vaccine Collaborative: a new model of coordinated discovery.

O'Donnell-Tormey J, McDermott EA Jr.

Cancer Immun. 2012;12:10. Epub 2012 May 1. No abstract available.

7.

T cell assays and MIATA: the essential minimum for maximum impact.

Britten CM, Janetzki S, Butterfield LH, Ferrari G, Gouttefangeas C, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Ottenhoff TH, Ottensmeier C, Pawelec G, Roederer M, Roep BO, Romero P, van der Burg SH, Walter S, Hoos A, Davis MM.

Immunity. 2012 Jul 27;37(1):1-2. doi: 10.1016/j.immuni.2012.07.010. No abstract available.

8.

Defining the critical hurdles in cancer immunotherapy.

Fox BA, Schendel DJ, Butterfield LH, Aamdal S, Allison JP, Ascierto PA, Atkins MB, Bartunkova J, Bergmann L, Berinstein N, Bonorino CC, Borden E, Bramson JL, Britten CM, Cao X, Carson WE, Chang AE, Characiejus D, Choudhury AR, Coukos G, de Gruijl T, Dillman RO, Dolstra H, Dranoff G, Durrant LG, Finke JH, Galon J, Gollob JA, Gouttefangeas C, Grizzi F, Guida M, Håkansson L, Hege K, Herberman RB, Hodi FS, Hoos A, Huber C, Hwu P, Imai K, Jaffee EM, Janetzki S, June CH, Kalinski P, Kaufman HL, Kawakami K, Kawakami Y, Keilholtz U, Khleif SN, Kiessling R, Kotlan B, Kroemer G, Lapointe R, Levitsky HI, Lotze MT, Maccalli C, Maio M, Marschner JP, Mastrangelo MJ, Masucci G, Melero I, Melief C, Murphy WJ, Nelson B, Nicolini A, Nishimura MI, Odunsi K, Ohashi PS, O'Donnell-Tormey J, Old LJ, Ottensmeier C, Papamichail M, Parmiani G, Pawelec G, Proietti E, Qin S, Rees R, Ribas A, Ridolfi R, Ritter G, Rivoltini L, Romero PJ, Salem ML, Scheper RJ, Seliger B, Sharma P, Shiku H, Singh-Jasuja H, Song W, Straten PT, Tahara H, Tian Z, van Der Burg SH, von Hoegen P, Wang E, Welters MJ, Winter H, Withington T, Wolchok JD, Xiao W, Zitvogel L, Zwierzina H, Marincola FM, Gajewski TF, Wigginton JM, Disis ML.

J Transl Med. 2011 Dec 14;9:214. doi: 10.1186/1479-5876-9-214.

9.

A methodological framework to enhance the clinical success of cancer immunotherapy.

Hoos A, Britten CM, Huber C, O'Donnell-Tormey J.

Nat Biotechnol. 2011 Oct 13;29(10):867-70. doi: 10.1038/nbt.2000. No abstract available.

PMID:
21997622
10.

Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond.

Britten CM, Janetzki S, van der Burg SH, Huber C, Kalos M, Levitsky HI, Maecker HT, Melief CJ, O'Donnell-Tormey J, Odunsi K, Old LJ, Pawelec G, Roep BO, Romero P, Hoos A, Davis MM.

Cancer Immunol Immunother. 2011 Jan;60(1):15-22. doi: 10.1007/s00262-010-0940-z. Epub 2010 Nov 16.

11.

Translation of cancer immunotherapies.

Skipper J, Hoffman EW, O'Donnell-Tormey J, Old LJ.

Nat Med. 2004 Nov;10(11):1154-5; author reply 1155. No abstract available.

PMID:
15516901
12.

Secretion of pyruvate. An antioxidant defense of mammalian cells.

O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la Harpe J.

J Exp Med. 1987 Feb 1;165(2):500-14.

13.

Resistance of human tumor cells in vitro to oxidative cytolysis.

O'Donnell-Tormey J, DeBoer CJ, Nathan CF.

J Clin Invest. 1985 Jul;76(1):80-6.

14.

Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.

O'Donnell-Tormey J, Quigley JP.

Proc Natl Acad Sci U S A. 1983 Jan;80(2):344-8.

15.
16.

Plasminogen activator and the membrane of transformed cells.

Quigley JP, Goldfarb RH, Scheiner C, O'Donnell-Tormey J, Yeo TK.

Prog Clin Biol Res. 1980;41:773-96.

PMID:
6256777

Supplemental Content

Loading ...
Support Center